<img src="https://ml.globenewswire.com/Resource/Download/8de285a8-2fd4-4052-87de-8a038c5ba2f1?size=2" nborder="0" align="left" hspace="5" vspace="5" title="Restem-cropped-1024x350-1.png" alt="Restem"/>MIAMI, June 17, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, Andres Isaias, will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:30%; width:30%; min-width:30%;">Date and Time:</td><td style="max-width:70%; width:70%; min-width:70%;">Tuesday, June 23, 2026, at 10:30 am PT</td></tr><tr><td>Format: </td><td>Corporate presentation and one-on-one meetings</td></tr><tr><td>Registration: </td><td><a href="https://www.globenewswire.com/Tracker?data=Ifnzq6PMwR3MsjpP4RqphFs2uPAqgGDjWaRhIl_grfR2xvIU_O4Q1hqrFzdqYqgtO511jek_05YlU8Yf8gV8BIJJgR-mpMZBv1Xbl8UtDqw=" rel="nofollow" target="_blank" title="Click here">Click here</a></td></tr></table> RESTEM's management team will be available throughout the conference to conduct one-on-one meetings with registered investors, strategic partners, and business development professionals About RESTEM RESTEM is a leading clinical-stage biotechnology company focused on developing off-the-shelf, next-generation cell therapies for autoimmune, inflammatory, and age-related diseases. Leveraging proprietary products, deep clinical expertise, and advanced manufacturing capabilities, RESTEM is advancing two potentially transformative programs, Restem-L, our umbilical cord lining progenitor cells (UMPCs) therapy for autoimmune diseases, and activated natural killer cell (aNK) therapeutics targeting senescence and age-associated disorders. Our therapies are designed to reprogram the immune system rather than focusing solely on symptom management, offering patients with limited options the potential to address underlying disease mechanisms. RESTEM is headquartered in Miami, Florida. For more information, please visit <a href="https://www.globenewswire.com/Tracker?data=ejsg7AF22tzfuxRhWqC3fRr12ILw_uHatt3G8muzmMueoG4-De1EqmZwaEHsb_vDTlZaeJbchuU8kkVN_RazJvvzs-gVduvTsVAHzqhABQqSxw-xdc3e5KwdXYqmdk3hOc6UWFGQKwBbXwIiFnbvdAhXCrqTsATvcIuG2FFNWNdBcBy3Kcc36tjCQyBUdZtuh_5PofitAeUn1q3pmJCtNV4oGd2GYDcRGSdokZELhwTbs_OG9N9_PdYhcfA9P98XBnVlxeEU1GKrF00wPoYj29iNU6bSqZetlAE6cBYNJrM9CC1Xdsl1BaNx3EBVpXhOflNAWncolmLIXQZsJsNFd3PHYaR81GGQzq51qmx1-NXebw8uLAqlPxwHRg-0ODIKq_xJ0fle2O-qLhB-2_LJdawVGIuEGjItc7aTNMQq6BXWVhi5d8m9UuOapEBG2HN9R2CtnDci9coodFfn6QkCZvq0z4Fb4KM4yGOWSuyZ9LH2u75mOIIl1lI6qBh4BAeEHlRT4KAyaIQe3uBuOnPJUHfJvIFqRQqvJxH4uxtPwp5H-3cX8kuZvRYbGHEQ19et6azeQ9yoJfAW8LsUtd1YHkenXGaS9ms11LPvnnRWyr9JY5MJmR119qsdtySdjiKcxx1C8swSXuHgPsLzystA8PJySPqceUkyS6M9h_czh7s=" rel="nofollow" target="_blank" title="www.restem.com">www.restem.com</a> and follow us on <a href="https://www.globenewswire.com/Tracker?data=KBtUKav7BXhZ2tBa8yCk2MAnWSlCmeaLRyxXgU4cQoeftjsn4xJuPX18GpB3185dp6E_n06zr8MeDVfYtIN3oI4iChQhr4Qy8xjXBw9M08AmBJQXT7egA9u2pVb3uqCHffAZmRezLxNxkILZnXRUDFiwyq7ZDS8zkGO5PSPKQAI_cJQ92twZqlYW6RWBZhRM02iSaXsVqBDwrZhF35qy9tXSize4GAqisKNymDdHdcZGQUmSg7qJIvspelCloRvtYjPCR-LUImqxtV26ZyNfumRSnMWjRmuuka5KwAVoSdkS9HaJ-CCu_8bXaEb1jB8L1LQemBTObPtP4nyXqY7kpjRLpnUSn07PKrp81aIYQmIM-YzYdbK-kcaoK8tfAw1HxaHj1xJrLZGm_I6eTpDb2K6h36RmprXVXDp9l-AONthWvA_yx8g5aQyz3SUTiP2LpPoYLl-Zfh4pWpVyaIC2E29yu7J4OAc0K6SzDM5UCjQC6pTG-7BtzE2Qj6XY9f5XQrZ_gUbxrnWF6o3GZ3mWzqAndSbbU18kIIcRvnNTLrMcz5ikiFYvinmpaUdX6oorzwB_R8sD3bBkRRvlajBPTqcA9vMDfbc6qxZTJWHcdh21Hyeedw6kyWn0vTsBCcb5YlZL0q7mhbWk_Pd9Cm17lLH04HN6xr3NMND-IDt3bS6YyblYT-qtODV0s3OUzqrnZeI7tCAGxWdM7gSBu4JgPgfROE6SZqg0ZSRbqtOUKBaM5koll5iPWlrTqPRau76a5pT0jaLtYLWS2UNggT70KWOpVlB2csCU1kzZfELjXVhk61P9yil9GlyK5diX9YKjuiL8IXEjZtgnIEx_m5TKNad-y3fjAcarIcSIygn70WTkUb71i0yoDKXTzCyebb5AHQQ-LhQ0y3aql55A9C4M9WteGrmDWzKSs9Oa5_zgTBY=" rel="nofollow" target="_blank" title="X">X</a> and <a href="https://www.globenewswire.com/Tracker?data=fCojhhUTyoXnVtpOR7zeACDaxzJ6BU8R_Zq8P-lhtnJc1M8yea-B9hu2WA03x4Asm85eQ8nmU5lf2lxNPsUPJ3iZ-2mG36yJ5LSVV9N3KOwqvLtgJF1BGsdNwbyqb6bQZCAIE2hSWR3z2dG7VjxyoZpyXPUikThNi3a9oQ394kzudWOE4Uodj4M1LlH5flC-FAoiSCOmoglIIux21U5_lIwpupKI8VE8YBUOnVb1Xkdv_RATZadtwcDI3xCp02PqAa74ZdAEOkAFz3A5HwrTmTqkLSoQPNhOZyt4bo78WU-ztZj3jMAWdilYNVc3SH4xDD2kDUrVY1QGI4ttrIj_7Ff-HqEqROteLU9Jr_K69dotQU86bU7WRHkGFUbVnEJ3IHooGNlLrH6tnmdaXxj9TcEkeW1z2GOqXdT7Nm9LgPhfms4V0yRDzYCmZJrbD0oLUNEkuIV14mZigVqlh76gYn6mBR5tTetj2oBLAOG0h2jW3273uI7c_xG2TV7bVJpdbQbRlWlQSHjNjNLt3J7LiEo9hHz4adwbBnL-3vy0B1dDPfkqTZtoeLb1_AlqILQm_4ssQBc3ajKoOlbf1pzbalGD-a7T92KSWYf678E6La7mbRc2DTFu7pjCevKn2VzASkf2wnCJxH5CvY2GLZdEXbOs4scxLcYHRFuEYZBFqjxXIWevAToyBx4MEV__m3NNZE9f8BddS-4YG1Yu1rMssaFvfLdxFnP_-063xNDX3VMLGXaGqpI47ceDQbgoIATWoFdusGozYbuHtVlKCZooYUJ3EVnDyUIZ1p2uKJ7a_ktPkuXzdWhtCpZID5GZ5gHtkppXLqkTzRi2zEAwI2sj8W_7_My4Nf1hOh8U5FGlclxmglcDHV18ZZzysEs5vmZspljvqf46eP8J3zs3NSQO03xzJgsUY1SA3t6db-dQ3f5EVu7H0m5J-VF-ehonuUOSwyMiCoIawvUWDaFJRKZbnnV1hQ14kjgABXheVQp4cCjud_IV8xfUb2CL5vmaCpwQMj7Luh6U9De-VTpFCDHGzQ==" rel="nofollow" target="_blank" title="LinkedIn">LinkedIn</a>. Investor Contact Daniel Ferry LifeSci Advisors +1.617.430.7576 daniel@lifesciadvisors.com Media Contact Nelson Cabatuan Restem Group, Inc. +1.800.490.0924 ncabatuan@restem.com <img alt="" src='https://ml.globenewswire.com/media/OWIzNThlODEtMTc0Yi00MjQ5LThlMmItNzA2Mzk4MDA1Y2ZjLTUwMDEzMDA2Ni0yMDI2LTA2LTE3LWVu/tiny/Restem.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

RESTEM to Present at BIO International Convention

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn